hmm here is what @Jasmin said "With falling revenue"
Here is what the company officially state via an ASX official announcement, take your pick and what may be true or false
REVENUE Revenue from all ordinary activities was $24 million, up 595% over FY2016. Top-line growth during the second year of true commercial sales further solidifies Alexium’s strong position in the specialty chemical supply market.
• Revenue from chemistry sales up 693% from $3M to $24M
Ann: Preliminary Final Report, page-92
-
- There are more pages in this discussion • 30 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
